红细胞血型抗原的最新研究进展

- 1. 江苏大学附属昆山医院(江苏昆山, 215300);
- 2. 江苏省昆山市第三人民医院;
- 3. 长春博讯生物技术有限责任公司;
- 4. 黑龙江省牡丹江市第二人民医院

详细信息

收稿日期: 2019-11-09

Recent research progress of erythrocyte blood group antigen

More Information

Received Date: 09 November 2019

摘要: 2019年10月国际输血协会（ISBT）公布了3个新的红细胞系统抗原,更新后红细胞血型系统已经达到39个,系统抗原数目达到330个。3个新发现的系统抗原是Kanno抗原（编号037）、SID抗原（编号038）、Ctl2抗原（编号039）。本文就红细胞血型抗原的最新研究进展,以及血型抗原的相关数据、基因位点、基因注册数据等,做归纳和简要综述。截至到目前,已发现的红细胞血型抗原有391个,其中经ISBT确认和命名的抗原有367个,
- 系统抗原 /
- 系列抗原 /
- 集合抗原 /
- 基因位点
Abstract: In October 2019,ISBT published 39 RBC blood group systems and 330 systemic antigens.So far,391 RBC blood group antigens have been identified,of which 367 have been identified as "system", "collection" and "series" antigens by ISBT,and 24 have not been identified and classified by ISBT.In this paper,we collate and list the related genes and molecular biology data of "system antigen",as well as related database registration data.
- system antigen /
- series antigen /
- collection antigen /
- gene locus

[1]	Storry JR,Clausen FB,Castilho L,et al.International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology:Report of the Dubai,Copenhagen and Toronto meetings[J].Vox Sang,2019,114(1):95-102.
[2]	McGuire BE,Hettle A,Vickers C,et al.The structure of a family 110 glycoside hydrolase provides insight into the hydrolysis of α-(1,3)-galactosidic linkages in λ-carrageenan and blood group antigens[J].J Biol Chem,2020.
[3]	Romero-Miguel D,Lamanna-Rama N,Casquero-Veiga M,et al.Minocycline in neurodegenerative and psychiatric diseases:an update[J].Eur J Neurol,2020 Nov 12.doi:10.1111/ene.14642.Epub ahead of print.
[4]	张志琴,李中华,张黎雯.Duffy血型抗原的G-蛋白偶联受体作用[J].临床血液学杂志,2019,32(2):162-166.
[5]	徐姿,李树中,李中华,等.Junier抗原的最新研究进展[J].临床血液学杂志,2019,32(4):322-326.
[6]	王鹤,李树中,李中华,等.RHAG血型抗原研究进展[J].临床血液学杂志,2019,32(6):479-482.
[7]	叶小英,李中华,李凌波,等.CD59-血型抗原的研究新进展[J].临床血液学杂志,2019,32(6):487-489.
[8]	张娇,李树中,李中华,等.Sda血型抗原研究进展[J].临床血液学杂志,2019,32(8):648-650.
[9]	胡氏月,李中华,吴建红,等.Globoside血型抗原研究进展[J].临床血液学杂志,2019,32(10):813-817.